Clinical Trials Search Results

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest
Display:
?
Cancer Type/Condition:  Retinoblastoma
Stage/Subtype:  intraocular retinoblastoma
Country:  U.S.A.
Trial Type:  Treatment
Results 1-6 of 6 for your search:
Start Over
Intra-arterial Melphalan in Treating Younger Patients with Localized Intraocular Retinoblastoma
Phase: Phase II
Type: Treatment
Age: 18 and under
Trial IDs: J1071, NCI-2011-00584, NA_000040637, NCT01293539
Simvastatin, Topotecan Hydrochloride, and Cyclophosphamide in Treating Younger Patients with Relapsed and/or Refractory Solid and CNS Tumors
Phase: Phase I
Type: Biomarker/Laboratory analysis, Treatment
Age: 1 to 29
Trial IDs: AFLACST1402, NCI-2015-00420, IRB00078790, NCT02390843
Conditioning Therapy Followed by Stem Cell Transplant in Treating Patients with High Risk or Relapsed Solid or Central Nervous System Tumors
Phase: No phase specified
Type: Treatment
Age: 70 and under
Trial IDs: 2011OC057, NCI-2013-02265, 1107M02641, MT2011-09C, NCT01505569
Cyclophosphamide or Thalidomide after Stem Cell Transplant in Treating Younger Patients with Solid Tumors
Phase: No phase specified
Type: Treatment
Age: 5 to 21
Trial IDs: 201209088, NCI-2012-01541, NCT01661400
Intra-arterial Melphalan in Treating Younger Patients with Unilateral Retinoblastoma
Phase: No phase specified
Type: Biomarker/Laboratory analysis, Treatment
Age: Children
Trial IDs: ARET12P1, NCI-2014-00618, NCT02097134
Combination Chemotherapy in Treating Patients with Newly Diagnosed, Previously Untreated Intraocular Retinoblastoma
Phase: No phase specified
Type: Treatment
Age: Not specified
Trial IDs: SJRET6, NCI-2013-00409, NCT01783535
Start Over